BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37992307)

  • 1. Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
    Mariniello A; Nasti TH; Chang DY; Hashimoto M; Malik S; McManus DT; Lee J; McGuire DJ; Cardenas MA; Umana P; Nicolini V; Antia R; Saha A; Buchwald Z; Kissick H; Ghorani E; Novello S; Sangiolo D; Scagliotti GV; Ramalingam SS; Ahmed R
    Clin Cancer Res; 2024 May; 30(9):1833-1845. PubMed ID: 37992307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
    Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
    Front Immunol; 2022; 13():869768. PubMed ID: 35774790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1
    Hudson WH; Gensheimer J; Hashimoto M; Wieland A; Valanparambil RM; Li P; Lin JX; Konieczny BT; Im SJ; Freeman GJ; Leonard WJ; Kissick HT; Ahmed R
    Immunity; 2019 Dec; 51(6):1043-1058.e4. PubMed ID: 31810882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
    Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.
    Penaloza-MacMaster P; Kamphorst AO; Wieland A; Araki K; Iyer SS; West EE; O'Mara L; Yang S; Konieczny BT; Sharpe AH; Freeman GJ; Rudensky AY; Ahmed R
    J Exp Med; 2014 Aug; 211(9):1905-18. PubMed ID: 25113973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
    Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PD-1 during effector CD8 T cell differentiation.
    Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
    Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R
    Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.
    Gill AL; Wang PH; Lee J; Hudson WH; Ando S; Araki K; Hu Y; Wieland A; Im S; Gavora A; Medina CB; Freeman GJ; Hashimoto M; Reiner SL; Ahmed R
    Sci Immunol; 2023 Aug; 8(86):eadg0539. PubMed ID: 37624909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.
    Vezys V; Penaloza-MacMaster P; Barber DL; Ha SJ; Konieczny B; Freeman GJ; Mittler RS; Ahmed R
    J Immunol; 2011 Aug; 187(4):1634-42. PubMed ID: 21742975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsets of exhausted CD8
    Miller BC; Sen DR; Al Abosy R; Bi K; Virkud YV; LaFleur MW; Yates KB; Lako A; Felt K; Naik GS; Manos M; Gjini E; Kuchroo JR; Ishizuka JJ; Collier JL; Griffin GK; Maleri S; Comstock DE; Weiss SA; Brown FD; Panda A; Zimmer MD; Manguso RT; Hodi FS; Rodig SJ; Sharpe AH; Haining WN
    Nat Immunol; 2019 Mar; 20(3):326-336. PubMed ID: 30778252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 combination therapy with IL-2 modifies CD8
    Hashimoto M; Araki K; Cardenas MA; Li P; Jadhav RR; Kissick HT; Hudson WH; McGuire DJ; Obeng RC; Wieland A; Lee J; McManus DT; Ross JL; Im SJ; Lee J; Lin JX; Hu B; West EE; Scharer CD; Freeman GJ; Sharpe AH; Ramalingam SS; Pellerin A; Teichgräber V; Greenleaf WJ; Klein C; Goronzy JJ; Umaña P; Leonard WJ; Smith KA; Ahmed R
    Nature; 2022 Oct; 610(7930):173-181. PubMed ID: 36171288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.
    Condotta SA; Khan SH; Rai D; Griffith TS; Badovinac VP
    J Immunol; 2015 Jul; 195(1):116-25. PubMed ID: 25980007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.
    Penaloza-MacMaster P; Provine NM; Blass E; Barouch DH
    J Immunol; 2015 Aug; 195(3):1054-63. PubMed ID: 26116499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
    Blackburn SD; Crawford A; Shin H; Polley A; Freeman GJ; Wherry EJ
    J Virol; 2010 Feb; 84(4):2078-89. PubMed ID: 19955307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.